BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 21900752)

  • 1. MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity.
    Stindt MH; Carter S; Vigneron AM; Ryan KM; Vousden KH
    Cell Cycle; 2011 Sep; 10(18):3176-88. PubMed ID: 21900752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sumoylation induced by the Arf tumor suppressor: a p53-independent function.
    Tago K; Chiocca S; Sherr CJ
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7689-94. PubMed ID: 15897463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific.
    Chang PC; Izumiya Y; Wu CY; Fitzgerald LD; Campbell M; Ellison TJ; Lam KS; Luciw PA; Kung HJ
    J Biol Chem; 2010 Feb; 285(8):5266-73. PubMed ID: 20034935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.
    Buschmann T; Fuchs SY; Lee CG; Pan ZQ; Ronai Z
    Cell; 2000 Jun; 101(7):753-62. PubMed ID: 10892746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDM2-ARF complex regulates p53 sumoylation.
    Chen L; Chen J
    Oncogene; 2003 Aug; 22(34):5348-57. PubMed ID: 12917636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Biotinylated SUMO-Traps to Analyze SUMOylated Proteins.
    Lang V; Da Silva-Ferrada E; Barrio R; Sutherland JD; Rodriguez MS
    Methods Mol Biol; 2016; 1475():109-21. PubMed ID: 27631801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMO-1 modification activates the transcriptional response of p53.
    Rodriguez MS; Desterro JM; Lain S; Midgley CA; Lane DP; Hay RT
    EMBO J; 1999 Nov; 18(22):6455-61. PubMed ID: 10562557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the p53 pathway by ubiquitin and related proteins.
    Hock A; Vousden KH
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1618-21. PubMed ID: 20601087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.
    Gostissa M; Hengstermann A; Fogal V; Sandy P; Schwarz SE; Scheffner M; Del Sal G
    EMBO J; 1999 Nov; 18(22):6462-71. PubMed ID: 10562558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MdmX inhibits ARF mediated Mdm2 sumoylation.
    Ghosh M; Weghorst K; Berberich SJ
    Cell Cycle; 2005 Apr; 4(4):604-8. PubMed ID: 15876864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nucleolar SUMO-specific protease SMT3IP1/SENP3 attenuates Mdm2-mediated p53 ubiquitination and degradation.
    Nishida T; Yamada Y
    Biochem Biophys Res Commun; 2011 Mar; 406(2):285-91. PubMed ID: 21316347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMO E3 ligase activity of TRIM proteins.
    Chu Y; Yang X
    Oncogene; 2011 Mar; 30(9):1108-16. PubMed ID: 20972456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif.
    Minty A; Dumont X; Kaghad M; Caput D
    J Biol Chem; 2000 Nov; 275(46):36316-23. PubMed ID: 10961991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between SUMOylation and NEDDylation regulates RPL11 localization and function.
    El Motiam A; Vidal S; de la Cruz-Herrera CF; Da Silva-Álvarez S; Baz-Martínez M; Seoane R; Vidal A; Rodríguez MS; Xirodimas DP; Carvalho AS; Beck HC; Matthiesen R; Collado M; Rivas C
    FASEB J; 2019 Jan; 33(1):643-651. PubMed ID: 30024791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA damage-induced heterogeneous nuclear ribonucleoprotein K sumoylation regulates p53 transcriptional activation.
    Pelisch F; Pozzi B; Risso G; Muñoz MJ; Srebrow A
    J Biol Chem; 2012 Aug; 287(36):30789-99. PubMed ID: 22825850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMO-specific protease SUSP4 positively regulates p53 by promoting Mdm2 self-ubiquitination.
    Lee MH; Lee SW; Lee EJ; Choi SJ; Chung SS; Lee JI; Cho JM; Seol JH; Baek SH; Kim KI; Chiba T; Tanaka K; Bang OS; Chung CH
    Nat Cell Biol; 2006 Dec; 8(12):1424-31. PubMed ID: 17086174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.
    Yang W; Sheng H; Thompson JW; Zhao S; Wang L; Miao P; Liu X; Moseley MA; Paschen W
    Stroke; 2014 Apr; 45(4):1115-22. PubMed ID: 24569813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
    Citro S; Chiocca S
    Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage.
    Park JH; Lee SW; Yang SW; Yoo HM; Park JM; Seong MW; Ka SH; Oh KH; Jeon YJ; Chung CH
    Nat Commun; 2014 Nov; 5():5483. PubMed ID: 25406032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.